Biblio

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

V

Pagliari MTeresa, Budde U, Baronciani L, Eshghi P, Ahmadinejad M, Badiee Z, Baghaipour M-R, Hidalgo OBenítez, Biguzzi E, Bodó I, et al. von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPS. J Thromb Haemost. 2023.

Pagliari MTeresa, Rosendaal FR, Ahmadinejad M, Badiee Z, Baghaipour M-R, Baronciani L, Hidalgo OBenítez, Bodó I, Budde U, Castaman G, et al. Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS-IPS study. J Thromb Haemost. 2022.

Lindsay J, Krantz EM, Morris J, Sweet A, Tverdek F, Joshi A, Yeh R, Hill JA, Greenwood M, Chen SC-A, et al. Voriconazole in hematopoietic stem cell transplantation and cellular therapies: Real-world usage and therapeutic level attainment at a major transplant center. Transplant Cell Ther. 2022.

Jørgensen KJuhl, Gøtzsche PC, Dalbøge CS, Johansen HKrogh. Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia. Cochrane Database Syst Rev. 2014;2:CD004707.

Bucknor MD, Gross AJ, Link TM. Voriconazole-induced periostitis in two post-transplant patients. J Radiol Case Rep. 2013;7(8):10-7.

Thekkudan SFrancis, Kumar P, Nityanand S. Voriconazole-induced skeletal fluorosis in an allogenic hematopoietic stem cell transplant recipient. Ann Hematol. 2016.

Alatrash G, Saberian C, Bassett R, Thall PF, Ledesma C, Lu Y, Daher M, Valdez BC, Kawedia J, Popat U, et al. Vorinostat combined with Busulfan, Fludarabine, and Clofarabine Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Leukemia: Long-term Study Outcomes. Transplant Cell Ther. 2022.

Nieto Y, Valdez BC, Thall PF, Ahmed S, Jones RB, Hosing C, Popat U, Shpall EJ, Qazilbash M, Gulbis A, et al. Vorinostat Combined with High-Dose Gemcitabine, Busulfan and Melphalan with Autologous Stem-Cell Transplantation in Patients with Refractory Lymphomas. Biol Blood Marrow Transplant. 2015.

Zierfuss B, Weinhofer I, Kühl J-S, Köhler W, Bley A, Zauner K, Binder J, Martinović K, Seiser C, Hertzberg C, et al. Vorinostat in the acute neuroinflammatory form of X-linked adrenoleukodystrophy. Ann Clin Transl Neurol. 2020.

Xu S, De Veirman K, Vanderkerken K, Van Riet I. Vorinostat-induced bone loss might be related to the drug toxicity. Bone. 2013.

Awan H, Balasubramaniam S, Odysseos A. A Voxel Model to Decipher the Role of Molecular Communication in the Growth of Glioblastoma Multiforme. IEEE Trans Nanobioscience. 2021;PP.

Tutak I, Özdil B, Uysal A. Voxtalisib and low intensity pulsed ultrasound combinatorial effect on glioblastoma multiforme cancer stem cells via PI3K/AKT/mTOR. Pathol Res Pract. 2022;239:154145.

Guo W, Tsujimura K, I MOtsuka, Irie K, Igarashi K, Nakashima K, Zhao X. VPA Alleviates Neurological Deficits and Restores Gene Expression in a Mouse Model of Rett Syndrome. PLoS One. 2014;9(6):e100215.

Li Y, Cui C, Xie F, Kiełbasa S, Mei H, van Dinther M, van Dam H, Bauer A, Zhang L, Dijke PTen. VprBP mitigates TGF-β and Activin signaling by promoting Smurf1-mediated type I receptor degradation. J Mol Cell Biol. 2019.

Nicholls H. VSELs: is ideology overtaking science?. Cell Stem Cell. 2013;13(2):143-4.

Chen D, Tan C, Ding P, Luo L, Zhu J, Jiang X, Ou Z, Ding X, Lan T, Zhu Y, et al. VThunter: a database for single-cell screening of virus target cells in the animal kingdom. Nucleic Acids Res. 2021.

Lee SKyun, Kim YSeon, Bae GHo, Lee HYoung, Bae Y-S. VU0155069 inhibits inflammasome activation independent of phospholipase D1 activity. Sci Rep. 2019;9(1):14349.

Kang Y-J, Clement EM, Park I-H, Greenfield LJohn, Smith BN, Lee S-H. Vulnerability of cholecystokinin-expressing GABAergic interneurons in the unilateral intrahippocampal kainate mouse model of temporal lobe epilepsy. Exp Neurol. 2021:113724.

Meyers LM, Krawic C, Luczak MW, Zhitkovich A. Vulnerability of HIF1α and HIF2α to damage by proteotoxic stressors. Toxicol Appl Pharmacol. 2022:116041.

Ishida Y, Kawakami H, Kitajima H, Nishiyama A, Sasai Y, Inoue H, Muguruma K. Vulnerability of Purkinje Cells Generated from Spinocerebellar Ataxia Type 6 Patient-Derived iPSCs. Cell Rep. 2016;17(6):1482-1490.

Sheng S, Bernardo M, Dzinic SH, Chen K, Sakr WA. The vulnerable primed cancer stem cells in disguise: demystifying the role of Maspin. Cancer Metastasis Rev. 2022.

Preston M, Richards A. Vulvar and Vaginal Graft Versus Host Disease After Allogeneic Stem Cell Transplant-A Systematic Review. J Low Genit Tract Dis. 2023;27(3):266-274.

Xu W, Moon A, Chetty N, Lourie R, Shannon C. Vulvar yolk sac tumor diagnosed during pregnancy, with recurrence during subsequent second pregnancy. Gynecol Oncol Rep. 2015;12:67-71.

Wu K, Feng J, Xiu Y, Li Z, Lin Z, Zhao H, Zeng H, Xia W, Yu L, Xu B. Vδ2 T cell subsets, defined by PD-1 and TIM-3 expression, present varied cytokine responses in acute myeloid leukemia patients. Int Immunopharmacol. 2020;80:106122.

W

Ding WYung, Huang J, Wang H. Waking up quiescent neural stem cells: Molecular mechanisms and implications in neurodevelopmental disorders. PLoS Genet. 2020;16(4):e1008653.

Pages